# Autologous Platelet-rich Plasma to Improve Responsiveness and Embryo Quality in Patients With Poor Ovarian Response

> **NCT05105724** · PHASE2 · UNKNOWN · sponsor: **Nanjing University** · enrollment: 50 (estimated)

## Conditions studied

- Infertility

## Interventions

- **BIOLOGICAL:** PRP

## Key facts

- **NCT ID:** NCT05105724
- **Lead sponsor:** Nanjing University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-20
- **Primary completion:** 2022-07-20
- **Final completion:** 2022-07-20
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05105724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05105724, "Autologous Platelet-rich Plasma to Improve Responsiveness and Embryo Quality in Patients With Poor Ovarian Response". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05105724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*